I. Introduction
Hepatocellular carcinoma (HCC) is the third most common cause of cancer mortality worldwide (1) In Egypt, the incidence rate of HCC was doubled in the past 10 years (2) It contributes to 14.8% of all cancer mortality in Egypt, with a higher incidence in males than in females. It is the second most frequent cancer type in Egyptian males and the eighth most frequent in Egyptian females (3) Liver cirrhosis is one of the underlying liver diseases that put patients at risk for the development of HCC (4). Emerging data indicate that the mortality rate of HCC associated with cirrhosis is rising in some developed countries, whereas mortality from non-HCC complications of cirrhosis is decreasing or is stable (5) HCC is usually asymptomatic in the early stages and tends to be invasive in late stages. Therefore, most patients present with an incurable disease at the time of detection, which makes early diagnosis of HCC critical for a good prognosis (6). Most imaging techniques help to discover HCC after considerable time of onset of tumor. In most instances, oncologists depend on AFP as the commonest and feasible marker for assessing HCC in addition to imaging (3) . However, AFP is not completely a reliable marker in early HCC diagnosis, prevention or therapy due to its low specificity and sensitivity. Liver biopsy is always considered as an invasive procedure, so chemical findings are still greatly appreciated (7) Talin-1 is a key adaptor protein that regulates integrin conformation and cell migration, and has been shown to play an important role in promoting tumor cell adhesion, migration and invasion in different types of cancer (8) monocyte chemoattractant protein-1(MCP-1) belongs to the family of chemotactic cytokines known as chemokines, was found to be secreted by mononuclear cells and various nonleukocytic cells (9) . Migration of monocytes from the blood stream across the vascular endothelium is required for routine immunological surveillance of tissues, as well as in response to inflammation (10). It has been demonstrated that MCP-1-mediated macrophage infiltration promotes tumor progression in various types of cancer (11).
Insulin-like growth factor 1 (IGF-1) is a protein produced primarily by the liver as an endocrine hormone as well as in target tissues in a paracrine/ autocrine fashion (3) IGF-1 potent survival factor and implicated in the development and progression of various cancers ( 12) Aim of the work: Evaluation of serum levels of monocyte chemoattractant protein-1 (MCP-1), talin-1& insulin like growth factor-1(IGF-1) in Egyptian patients with HCC compared to liver cirrhosis& healthy controls and to find their values in HCC prediction.
Subjects and Methods:
This study was carried out at Clinical Pathology, Medical Biochemistery Departments and Oncology Institute, Faculty of Medicine, in collaboration with Hepatology Department, National Liver Institute, Menoufia University, in the duration between June 2013 and June 2016.
I-Subjects:
The study included 64 patients from those attending the Outpatient Clinic and inpatients of Hepatology Department of National Liver Institute and Oncology Institute. They were classified as follow: 25 patients with liver cirrhosis, 39 patients suffering from HCC on top of liver cirrhosis. In addition to 24 apparently healthyage and gender matched-subjects considered as the control group. All individuals were subjected to complete physical examination, routine biochemical tests, serum AFP, taline-1, MCP-1 & IGF-1 determinations and abdominal ultrasonography. Patients with liver cirrhosis were diagnosed by clinical & biochemical examinations, ultrasonography and computerized tomography. Patients with HCC were diagnosed by triphasic CT.
The study design was accepted by the local Ethics Committee. Informed consents were obtained from the shared subjects. Any patient with cardiac, respiratory or renal dysfunction was excluded. Diabetic patients, patients with evidence of recent systemic infection or active variceal bleeding, hepatic encephalopathy or spontaneous bacterial peritonitis were also excluded. None of the control group was suffering from any other medical conditions.
II. Methods

 Sampling:
Samples are taken under complete aseptic conditions, after an overnight fasting ; 7 ml venous blood sample of all subjects were taken and collected in a sterile tube, allowed to clot and centrifuged at 3000 rpm for 15 minutes for separating the serum to assess ALT, AST, ALP, total and direct bilirubin, creatinine and BUN. The residual serum were divided in 4 aliquots and stored at -20 C for measuring of AFP , IGF-I, MCP-1& taline-1 .
 Laboratory methods:
Biochemical tests for detection of liver function were done on Synchron CX9 autoanalyser using kit supplied by Beckman (Beckman Instrument. Inc.Fullerton, California USA). Hepatitis viral markers (HBsAg and HCV Ab) done by "ECLIA" using Cobas 411 analyzers ( Roche diagnostics,Germany).Serum Talin-1 MCP-1, IGF-1 and AFP using enzyme linked immunesorbent assay (ELISA) Serum Talin-1 assayed by using enzyme linked immunesorbent assay (ELISA) which supplied by WKEA MED SUPPLIES CORP, NEW YORK, USA. The assay kit measures human Talin-1 level in serum samples using purified human Talin antibody to coat microtiter plate wells and make solid-phase antibody, then addition of Talin to wells, combined Talin which with enzyme labeled, become antibody-antigen-enzyme-antibody complex, after complete washing, substrate is added, substrate becomes blue color which is HRP enzyme-catalyzed reaction. This reaction is terminated by addition of sulphuric acid solution and the color changes to yellow and its intensity is measured spectrophotometrically at a wavelength of 450 nm. The concentration of Talin in the samples is then determined by comparing the O.D. of the samples to the standard curve. MCP-1 level assayed by ELISA kit supplied by WKEA MED SUPPLIES CORP( NEW YORK, USA) by using purified human MCP-1 antibody to coat microtiter plate wells and make solid-phase antibody, then addition of MCP-1 to wells, combined MCP-1 which with enzyme labeled, become antibody-antigen-enzyme-antibody complex, after complete washing, 
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III. Analytic statistics
The statistical analysis was undertaken using SPSS software (version 17; SPSS Inc., Chicago, IL, USA). Descriptive statistics in the form of mean and standard deviation for parametric data were used. Chisquare test (χ2) was used for two qualitative variables. Kruskal-Wallis test for comparison between three groups not normally distributed having quantitative variables, followed by LSD (least significant difference. Pearson correlation coefficient (r) used to test correlation between two quantitative variables.diagnostic sensitivity , specificity ,positive predictive value (PPV),negative predictive value (NPV) ,diagnostic accuracy and Receiver Operator Characteristic Curve (ROC) a graphic representation of the relationship between sensitivity and specificity at different cut-off points for a diagnostic test The significance level was set at 0.05.
Results:
Results are explained in tables,
IV. Discussion
The serum alpha-fetoprotein (AFP) is the most commonly used HCC biomarker, However, its poor sensitivity and specificity renders it unsatisfactory for this purpose.The prognosis of HCC is very difficult which necessitates finding of new appropriate either single or panel serum markers that could be used for early detection of HCC in high risk patients like patients with liver cirrhosis (13) Taline-1 is a large cytoskeletal dimeric adaptor protein that associates with the integrin family of cell adhesion molecules in cell extracellular matrix junctions where it both activates integrins and couples them to the actin cytoskeleton (14) The current study showed high significant increases in the serum level of talin-1 in HCC patients in comparison with both cirrhotic and control groups. Also, there was a high significant increase in cirrhotic patients compared with the controls. These results are similar to that of Youns et al., [15] who found that serum talin-1 levels were significantly higher in the HCC group than in the liver cirrhosis group and controls. Moreover, (14)Kanamori et al.,reported that talin-1 expression levels in HCC nodules identified by differential tissue proteome were significantly associated with undifferentiated HCC and showed correlation between talin-1 upregulation and a shorter time to recurrence after resection. In addition, Fang et al., [16] reported that high levels of talin-1 expression is correlated with tumorigenicity in human HCC, indicating that these molecules constitute important molecular targets for the diagnosis and/or treatment of HCC. On the other hand, (17) Zhang et al. have proved that taline-1 is down-regulated in HCC liver tissues when compared with adjacent non-cancerous liver tissues or with control liver tissues by immuno-histochemistry and real time PCR .
By using pearsons correlation in patients with HCC, only a positive correlation was found between taline-1 and AFP. Meanwhile, no correlations were found between taline-1 and other studied parameters. (15)Youns et al., found no significant correlations between taline-1 and other biochemical variables in patients with HCC.In the current study and by using ROC curve, the best cutoff of talin-1 that can ` discriminate HCC patients from cirrhotic was at 17.24 ng/ml with a sensitivity of 97% , specificity of 100 % and diagnostic accuracy of 96 % . Moreover, ROC curve analysis showed AUC for taline-1 was higher than that of AFP (sensitivity of 95% , specificity of 80 %) . Parallel combination of AFP and taline-1 raise the sensitivity and specificity up to 100% and 84% , respectively. Our results were in agreement with Youns et al., [15] who studied the diagnostic utility of talin-l in diagnosis of HCC, they found that at acutoff value of 33.7 ng/ml the diagnostic sensitivity was 100% and specificity 87%. ROC curve analysis showed AUC for taline-1 was higher than that of AFP alone or in combination with taline.
MCP-1 is a member of the small inducible gene family, and plays a role in the recruitment of monocytes to sites of injury and infection, its expression may plausibly be associated with HCC development (18) .The current study showed a highly significant increase in the serum level of MCP-1 in HCC patients in comparison with other groups. The results are similar to that of Wang et al., (19) who found that serum MCP-1 levels were significantly higher in the HCC group than in the cirrhotic group or the controls. However, our rsults revealed that no statistical significant difference was found between patints with liver cirrhosis and the (20) found that there was a significant increase in level of MCP-1 in patients with all grades of hepatic affection in comparison to controls. The association between MCP-1 and liver damage has been implied due to the findings that specific non-malignant cells are major source of MCP-1, such as the hepatic stellate cells that are known to be involved in the development of fibrosis and cirrhosis [21] , [22] . Meanwhile, and in coressponding to our results, Lin et al., stated that in HCC, HCC cells and cancer-associated fibroblasts are prominent contributors of MCP-1, regardless of whether the liver is cirrhotic (23) . By using pearsons correlation, MCP-1 was positively correlated with ALT/AST ratio. No correlations were found between the studied marker and the other parameters. Wang et al., (19) found no significant correlation between MCP-1 and liver function tests. ROC curve analysis revealed that at a cutoff level of 52.0 ng/ml, MCP-1 can discriminate between HCC and cirrhotic patients with a sensitivity of 100 % which was higher than both AFP and taline-1. The specificity of MCP-1 was 80% which equal to that of AFP and lower than that of taline-1. Parallel combination of AFP and MPC-1 only improve the sensitivity of AFP to reach 100% . parallel combination of MCP-1 and taline-1add nothing to the value of sensitivity and specificity of MCP-1. These data suggested that serum level of MCP-1 could be used as a screening marker for early detection of HCC with a reasonable diagnostic accuracy.
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IGF signaling system plays a pivotal role in the development and progression of various cancers ( 24) . However, the relevance of IGF-I to hepatocellular carcinoma is somewhat different from other malignancies because the majority of circulating IGF-I is produced by the liver (25) .
The obtained results revealed the presence of significant decrease in cirrhotic and HCC patients comparing with the controls. Meanwhile, no statistical significant difference was found between the cirrhotic and HCC patient groups. the obtained data were near those obtaind by Su et al., [26] who demonstrate that the development of HCC is accompanied by a significant reduction of serum IGF-I levels in comparison to healthy subjects which is also noted in chronic liver disease. To the opposite of our results, Aleem et al., [3] reported that the reduction of IGF-1 levels was statistically significant between cirrhosis and HCC patients. As regarding the decrease in IGF-1 in cirrhotic patients than healthy subjects many studies contribute this decrease to affection of liver parenchyma that reduce synthetic capability of damaged hepatocytes because hepatocytes are the main contributors of circulating IGF.The present study showed that there were significant positive correlations between IGF-1 level and total protein, albumin and MCP-1. Meanwhile, no correlation was observed with other variables including taline-1. By using ROC curve analysis the diagnostic accuracy of IGF-1 in the early detection of HCC was poor as AUC was in the range 57.4 with a sensitivity of 51% and specificity of 20%.
V. Conclusion
Our findings support the potential role of MCP-1 & taline-1 in as screening markers for HCC in cirrhotic patients. The early detection of HCC and discrimination of malignant from the cirrhotic cases is a challenge for the oncologists so, continuous and regular monitoring systems using MCP-1 or the combination of taline-1 with AFP could improve the diagnostic performance over AFP alone in the early detection of HCC in patients with liver cirrhosis. The cost benefit should be put in consideration to determine how far using these markers could improve the chances for early detection of HCC in patients at risk-as those with liver cirrhosiscould improve their prognosis and survival rate. 
